Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hamlet Pharma

Hamlet Pharma
PUBLIC STATUS
1-10 EMPLOYEES
HAMLET STOCK SYMBOL
$3.21 SHARE PRICE (As of Thursday Closing)
Description

Hamlet Pharma AB is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Medical Supplies
Other Industries
Drug Discovery
Drug Delivery
Stock Exchange
SAT
Primary Office
  • Klinikgatan 32
  • 222 42 Lund
  • Sweden

+46 040-12 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hamlet Pharma’s full profile, request a free trial.

Hamlet Pharma Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.43 - $6.40 $105M $3.31 -$0.06 32.8K 31.6M

Hamlet Pharma Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value 130,022 89,942 36,540 21,353
Revenue 0 0 0 0
EBITDA (1,784) (1,833) (1,923) (1,230)
Net Income (1,811) (1,868) (1,961) (1,548)
Total Assets 621 1,216 1,833 3,890
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hamlet Pharma Executive Team (2)

Name Title Board
Seat
Contact
Info
Mats Persson Chief Executive Officer
Catharina Svanborg Founder & Chairman

Hamlet Pharma Board Members (1)

Name Representing Role Since Contact
Info
000000000 00000000 Hamlet Pharma Founder & Chairman 000 0000